Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test

Impact of Routine Measurement of Serum Calcitonin on the Diagnosis and Outcome of Medullary Thyroid Cancer: Experience in 10,864 Patients with Nodular Thyroid Disorders

Rossella Elisei, Valeria Bottici, Fabiana Luchetti et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 534 citations · Full text

Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours

Stefan Adams, Richard P. Baum, Thomas Rink et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1997 · 388 citations

Positron Emission Tomography, Neuroendocrine Tumours, Engineering +10

Predictive Value of Serum Calcitonin Levels for Preoperative Diagnosis of Medullary Thyroid Carcinoma in a Cohort of 5817 Consecutive Patients with Thyroid Nodules

Giuseppe Costante, Domenico Meringolo, Cosimo Durante et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 369 citations

Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study

Frank Gr�nwald, Thomas K�licke, Ulrich Feine et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1999 · 342 citations

Positron Emission Tomography, Engineering, Oncologic Imaging +10

Imaging Medullary Thyroid Carcinoma with Persistent Elevated Calcitonin Levels

Anne‐Laure Giraudet, D. Vanel, Sophie Leboulleux et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 261 citations